arrow
Back
M

Marco Colleoni

irccs

102H-index
837Paper Count
4.9WCitation Count
Published Papers 320
Publication Date
Primary results from EL1SSAR, a prospective phase IIIb study of first-line atezolizumab plus nab-paclitaxel therapy for patients with PD-L1-positive advanced triple-negative breast cancer
err2026-06-08
err0
errOAAI
errL. Gianni; S. Delaloge; E. Ciruelos; O. Trédan; C. Castañeda; M.H. Abreu; I. Paris; M. Colleoni; G. Scandurra; M. Kwiatkowski; N. Antone; V. Gregorc; P. Tagliaferri; S. Borštnar; I. Blancas; M. Raimondo; M. Alfie; C. Arce-Salinas; P.S. Madeira; Y.G. Lin
errShare
errSave
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer
err2026-06-01
err0
PREAI
errP.A. Francis; O. Pagani; G.F. Fleming; B.A. Walley; M. Colleoni; G. Rubovszky; C. Tondini; E.M. Ciruelos; H.L. Gomez; H.R. Bonnefoi; H.J. Burstein; C. Chini; F. Puglisi; S. Spazzapan; A. Bernardo; M.A. Climent; M. Bellet; T. Ruhstaller; B. Bermejo; S.K.L. Chia
errShare
errSave
Updated Results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) Trial
err2026-05-28
err0
PREAI
errOlivia Pagani; Samuel M. Niman; Monica Ruggeri; Fedro A. Peccatori; Hatem A. Azim; Marco Colleoni; Cristina Saura; Chikako Shimizu; Anna Barbro Sætersdal; Judith R. Kroep; Ellen Warner; Frédéric Amant; Audrey Mailliez; Halle C.F. Moore; Manuel Ruiz-Borrego; Janice M. Walshe; Virginia F. Borges; Andrea Gombos; Akemi Kataoka; Christine Rousset-Jablonski
errShare
errSave
A chemotherapy-free, pathological response-adapted strategy using trastuzumab–pertuzumab and T-DM1 in HER2-positive early breast cancer: the PHERGain-2 study☆
err2026-05-06
err0
errOAAI
errL. Garrigós; M. Ruiz-Borrego; J.M. Pérez-García; A. Guerrero-Zotano; A. Cortés-Salgado; S. Kuemmel; M. Colleoni; C. Reboredo-Rendo; B. Bermejo; I. Blancas; J. Gavila; A. Fabi; C. Morales; A. Stradella; V. Carañana; E. Martínez-de Dueñas; C. Albacar; O. Ballesteros-Cidras; G. Martrat; S. Iacobucci
errShare
errSave
Inadequate ovarian function suppression and endocrine therapy manipulations in premenopausal patients with early breast cancer on adjuvant LHRH agonist and aromatase inhibitor: a cohort study☆
err2026-02-05
err0
errOAAI
errC. Valenza; J.D. Etessami; M. Milano; N. Papadopoulos; M. Alvino; G. Antonarelli; N. Bianco; C. Sangalli; D. Trapani; G. Pravettoni; E. Omodeo Salè; R. Passerini; M. Colleoni; E. Munzone; G. Curigliano
errShare
errSave
Identifying Premenopausal Patients with Early-Stage Hormone Receptor–Positive Breast Cancer at Minimal Risk of Distant Recurrence by Breast Cancer Index
err2026-01-29
err0
errOAAI
errRuth M. O’Regan; Yue Ren; Yi Zhang; Gini F. Fleming; Prudence A. Francis; Olivia Pagani; Barbara A. Walley; Roswitha Kammler; Patrizia Dell’Orto; Giuseppe Viale; Sherene Loi; Marco Colleoni; Kai Treuner; Meredith M. Regan
errShare
errSave
Metastasis-directed thermal ablation in patients with metastatic breast cancer and visceral oligoprogression or oligopersistence: a cohort study
err2025-11-26
err0
errOAAI
errNadia Bianco; Carmine Valenza; Monica Milano; Roberta Multinu; Elena Battaiotto; Matteo Cavallone; Giulia Malvezzi; Dario Trapani; Paolo Della Vigna; Guido Bonomo; Gianluca M. Varano; Daniele Maiettini; Maria Giovanna Pitoni; Claudia Sangalli; Elisabetta Munzone; Giuseppe Curigliano; Marco A. Colleoni; Franco Orsi
errShare
errSave
Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR+/HER2+ early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17)
err2025-10-16
err0
PREAI
errL. Malorni; S. Tyekucheva; A. Gombos; U. Hasler-Strub; C. Zamagni; C. Chakiba-Brugère; M. Colleoni; A. Mueller; A.M. Minisini; D. Taylor; J.P. Salmon; E. Gallerani; A. Cariello; A. Fontana; H. Roschitzki-Voser; R. Kammler; B. Ruepp; S. Loi; G. Viale; M.M. Regan; E. Brain; L. Biganzoli
errShare
errSave
Tumor-specific major histocompatibility-II expression predicts pathological complete response to atezolizumab combined to chemotherapy in triple-negative breast cancer
err2025-09-29
err0
errOAAI
errJustin M. Balko; Luca Licata; Xiao Qian Wang; Matteo Dugo; Chiun-Sheng Huang; Daniel Egle; Begoña Bermejo; Claudio Zamagni; Marc Thill; Antonio Anton; Stefania Russo; Elena Sevillano; Eva Maria Ciruelos; Richard Greil; Vladimir Semiglazov; Marco Colleoni; Catherine M. Kelly; Gabriella Mariani; Lucia Del Mastro; Stefania Zambelli; Giulia Viale; Maurizio Callari; Giuseppe Viale; Lajos Pusztai; Luca Gianni; H. Raza Ali; Giampaolo Bianchini
errShare
errSave
Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFT
errCancer
IF5.1
err2025-09-23
err0
PREAI
errKarin Ribi PhD; Bernard F. Cole PhD; Gini F. Fleming MD; Barbara A. Walley MD; Prudence A. Francis MD; Ehtesham Abdi MD; Harold J. Burstein MD, PhD; Kit L. Cheng MD; Stephen K. L. Chia MD, FRCP; Shaker R. Dakhil MD; Nancy E. Davidson MD; Stephen A. Della-Fiorentina MD; Ashley E. Frith MD; Ellis Levine MD; Sasha Lupichuk MD; Kathleen Pritchard MD; Muhammad Salim MD; Vered Stearns MD; Josephine Stewart MD; Vicente Valero MD; Andre van der Westhuizen MD; Olivia Pagani MD; Sherene Loi MD, PhD; Marco Colleoni MD; Richard D. Gelber PhD; Aron Goldhirsch MD; Alan S. Coates MD; Meredith M. Regan ScD; Jürg Bernhard PhD
errShare
errSave
Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]
err2025-09-22
err0
PREAI
errIsabelle Demeestere; Samuel M. Niman; Ann H. Partridge; Daniela S. Diego; Roswitha Kammler; Monica Ruggeri; Marco Colleoni; Chikako Shimizu; Cristina Saura; Karen A. Gelmon; Anna B. Saetersdal; Judith R. Kroep; Audrey Mailliez; Frederic Amant; Manuel Ruız-Borrego; Jeong Eon Lee; Akemi Kataoka; Janice M. Walshe; Junko Takei; Simona Borstnar; Virginia F. Borges; Christobel Saunders; Snezana Susnjar; Vesna Bjelic-Radisic; Fatima Cardoso; Jane Lowe Meisel; Jennifer F. Kawwass; Tanja Spanic; Sarra El-Abed; Martine Piccart; Larissa A. Korde; Aron Goldhirsch; Richard D. Gelber; Olivia Pagani; Hatem A. Azim; Fedro A. Peccatori
errShare
errSave
Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group
err2025-08-07
err0
errOAAI
errGiovanni Corso; Sherry Shen; Carmen Criscitiello; Rita Mukhtar; Lauren Gamble; Elena Guerini Rocco; Filippo Pesapane; Luca Nicosia; Komal Jhaveri; Beatrice Taurelli Salimbeni; Giulia Massari; Eleonora Meduri; Alessandra Margherita De Scalzi; Alberto Concardi; Francesca Magnoni; Anita Mamtani; Fresia Pareja; Maria Cristina Leonardi; Virgilio Sacchini; Giorgio Bogani; Carlo La Vecchia; Daniele Presti; Marco Angelo Colleoni; Paolo Veronesi; Mark E. Robson
errShare
errSave
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial
err2025-07-26
err0
errOAAI
errIsabelle Demeestere; Samuel M. Niman; Ann H. Partridge; Daniela S. Diego; Roswitha Kammler; Monica Ruggeri; Marco Colleoni; Chikako Shimizu; Cristina Saura; Karen A. Gelmon; Anna B. Saetersdal; Judith R. Kroep; Audrey Mailliez; Frederic Amant; Manuel Ruız-Borrego; Jeong Eon Lee; Akemi Kataoka; Janice M. Walshe; Junko Takei; Simona Borstnar; Virginia F. Borges; Christobel Saunders; Snezana Susnjar; Vesna Bjelic-Radisic; Fatima Cardoso; Jane Lowe Meisel; Jennifer F. Kawwass; Tanja Spanic; Sarra El-Abed; Martine Piccart; Larissa A. Korde; Aron Goldhirsch; Richard D. Gelber; Olivia Pagani; Hatem A. Azim; Fedro A. Peccatori
errShare
errSave
Invasive Pleomorphic Lobular Carcinoma of the breast: Clinicopathological features, treatment patterns and outcomes
errEJSO
IF2.9
err2025-06-01
err0
PREAI
errPeradze, N.; Polizzi, A.; Pagan, E.; Bottazzoli, E.; Bagnardi, V; Sangalli, C.; Morigi, C.; De Camili, E.; Raviele, P. Rafaniello; Corso, G.; Galimberti, V; Colleoni, M.; Veronesi, P.
errShare
errSave
Patient adherence to evidence-based and guidelines-consistent bone health monitoring intervention
errBREAST
IF7.9
err2025-02-01
err0
errOAAI
errBianco, N.; Martella, S.; Milano, M.; Manzoni, M. F.; Mariani, C.; Galimberti, V.; Sangalli, C.; Trapani, D.; Munzone, E.; Colleoni, M. A.
errShare
errSave
TAPSE/sPAP ratio can be used to predict pulmonary hypertension in fibrosing interstitial lung disease
err2024-07-01
err0
PREAI
errSonaglioni, A.; Caminati, A.; Zompatori, M.; Cassandro, R.; Colleoni, M.; Luisi, F.; Elia, D.; Lombardo, M.; Harari, S.
errShare
errSave
IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer
err2024-07-01
err4
errOAAI
errDent, R.; Andre, F.; Goncalves, A.; Martin, M.; Schmid, P.; Schuetz, F.; Kuemmel, S.; Swain, S. M.; Bilici, A.; Loirat, D.; Valencia, R. Villalobos; Im, S. -A; Park, Y. H.; De Laurentis, M.; Colleoni, M.; Guarneri, V.; Bianchini, G.; Li, H.; Machackova, Z. Kirchmayer; Mouta, J.; Deurloo, R.; Gan, X.; Fan, M.; Mani, A.; Swat, A.; Cortes, J.
errShare
errSave
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES ASSOCIATED INTERSTITIAL PNEUMONIA: A NEW CLINICAL ENTITY?
err2024-06-01
err0
PREAI
errPellico, M. R.; Iannone, C.; Caminati, A.; Tescaro, L.; Luisi, F.; Elia, D.; Mirenda, M. R.; Colleoni, M.; Cassandro, R.; Harari, S.; Caporali, R. F.
errShare
errSave
PARSIFAL-LONG: Extended follow-up of hormone receptor-positive/ HER2-negative advanced breast cancer patients treated with fulvestrant and palbociclib vs. letrozole and palbociclib in the PARSIFAL study
err2024-05-02
err2
PREAI
errLlombart-Cussac, Antonio; Perez-Garcia, Jose Manuel; Bellet-Ezquerra, Meritxell; Dalenc, Florence; Gil-Gil, Miguel; Ruiz-Borrego, Manuel; Gavila, Joaquin; Schmid, Peter; Zamora, Pilar; Wheatley, Duncan; Martinez-de Duenas, Eduardo; Amillano, Kepa; Anton, Antonio; Cottu, Paul; Vinas, Gemma; Petit, Thierry; Tesarova, Petra; Cueva, Juan; Colleoni, Marco; del Prado, Maria Purificacion Martinez; Andres, Raquel; Cabo, Marta Diaz; Victorino, Susana; Sampayo-Cordero, Miguel; Cortes, Javier
errShare
errSave
Final results from the phase 2, open-label FOENIX-MBC2 study: efficacy and safety of futibatinib in adult patients with locally advanced/metastatic HR+/HER2-breast cancer harboring high-level FGFR1 gene amplification
err2024-05-02
err0
PREAI
errDamodaran, Senthil; Andre, Fabrice; Unni, Nisha; Ferreira, Marta; Giridhar, Karthik; Daniel, Brooke; Colleoni, Marco; Costa, Luis; Bachelot, Thomas; O'Brien, Ciara; Wright, Gail; Shimura, Masashi; Tomlinson, Gareth; Gil, Maciej; Turner, Nicholas
errShare
errSave